TITLE

Review: Haloperidol does not reduce agitation in dementia

AUTHOR(S)
Wilkinson, David
PUB. DATE
May 2002
SOURCE
ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p105
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on a study which investigated the use of haloperidol for agitation in dementia. Effectiveness of haloperidol on patients with dementia; Side effects which may have confounded any reductions in psychotic symptoms.
ACCESSION #
8856106

 

Related Articles

  • Continuum of care: Stabilizing the acutely agitated patient. Bellnier, Terrance J. // American Journal of Health-System Pharmacy;9/1/2002 Supplement 5, Vol. 59, pS12 

    The safety and efficacy of i.m. ziprasidone and olanzapine for treating acute agitation in patients with factors to consider when evaluating the cost-effectiveness of these agents. Agitation is defined as excessive motor and verbal activity. Acute agitation has traditionally been treated with...

  • butyrophenone.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p333 

    An encyclopedia entry for the drug butyrophenone, which is used for treating psychoses, acute agitation and other disorders, is presented.

  • Agitation and Delirium at the End of Life. Breithart, William; Alici, Yesne // JAMA: Journal of the American Medical Association;12/24/2008, Vol. 300 Issue 24, p2898 

    A quiz concerning the clinical management of agitation and delirium at the end of life is presented.

  • Agitation Therapy for Antisocial and Psychopathic Personalties: An Outline. Martens, Willem H.J. // American Journal of Psychotherapy;Spring2001, Vol. 55 Issue 2, p234 

    In this paper, a hypothetical model of agitation therapy for some categories of antisocial and psychopathic patients/offenders is presented. Agitation therapy is mainly meant for very problematic and aggressive individuals who do not (or hardly) respond (in some periods) to any other type of...

  • 10 mg intramuscular olanzapine reduces acute agitation in schizophrenia more effectively than lower doses. Breier, A.; Meehan, K.; Birkett, M. // Evidence Based Mental Health;Feb2003, Vol. 6 Issue 1, p27 

    Determines the efficacy and safety of intramuscular olanzapine for acute agitation in schizophrenia. Dose-response relationship; Tools used to measure agitation; Finding that olanzapine reduced excitement and agitation in schizophrenics; Confirmation of the effectiveness of olanzapine in...

  • Non-drug interventions effective in managing agitation in dementia. Nazarko, Linda // Nursing & Residential Care;Feb2015, Vol. 17 Issue 2, p67 

    No abstract available.

  • The Effect of Clonidine Premedication on Postoperative Agitation. Nelson, Leonard B. // Journal of Pediatric Ophthalmology & Strabismus;May2013, Vol. 50 Issue 3, p139 

    The author discusses the benefits of clonidine premedication to reduce postoperative agitation following strabisumus surgery.

  • Promazine.  // Reactions Weekly;Jul2014, Vol. 1509 Issue 1, p28 

    The article presents a case study of a 61-year-old man who was diagnosed with neuroleptic syndrome while being medicated with promazine for agitation.

  • Additional use of methotrimeprazine for treating refractory agitation in pediatric patients. Zwaan, Sanne; Blankespoor, Roos; Wolters, Anton; Creten, Caroline; Leroy, Piet; Schieveld, Jan // Intensive Care Medicine;Jan2012, Vol. 38 Issue 1, p175 

    A letter to the editor is presented regarding the use of methotrimeprazine for pediatric refractory agitation (RA) treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics